CLDX
Celldex Therapeutics, Inc
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Best Diagnostics Stocks 2026 →
Celldex Therapeutics (CLDX) Stock: Buy, Sell, or Hold?
$30.65
-0.59 (-1.89%)
▼
5d:
+3.16%
30d:
+4.15%
90d:
-31.69%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (63%)
Quality Score
63/100
Position
EXTENDED
30-Day Fair Range
$28.62 – $30.95
Position: EXTENDED
Forward P/E & Valuation
-7.3x
Next 12M consensus est.
Wall Street Target
$64.00
+108.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$27.82 / $31.71
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: CLDX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When CLDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CLDX is currently trading at $30.65, which is considered extended relative to its 30-day fair value range of $28.62 to $30.95.
Technical Outlook: Technically, CLDX is in a uptrend. Immediate support is located at $27.82, while resistance sits at $31.71.
Market Sentiment: CLDX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $64.00 (+108.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CLDX is in a uptrend. Immediate support is located at $27.82, while resistance sits at $31.71.
Market Sentiment: CLDX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $64.00 (+108.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.62 -
$30.95
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
Trading Range & Key Levels
30-Day Trading Range
$28.62 -
$30.95
Current vs Trading Range
EXTENDED
Support Level
$27.82
Resistance Level
$31.71
Current Trend
Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 108.8% below Wall St target ($64.00)
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-7.28
Wall Street Target
$64.00
(+108.8%)
Revenue Growth (YoY)
-97.0%
Share CLDX Analysis
Share this live CLDX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CLDX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $CLDX with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 10:00 PM ET
Data refreshes hourly during market hours. Next update: 11:00 PM
Data refreshes hourly during market hours. Next update: 11:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 37 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 43 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 36 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 49 HOLD |
|
CGEM
Cullinan Oncology LLC |
STRONG BUY
12 analysts |
$35 | 57 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CLDX Research Pages
